Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Balance and Gait in People with Multiple Sclerosis: A Comparison with Healthy Controls and the Immediate Change after an Intervention based on the Bobath Concept.
Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
Disclosing the diagnosis of multiple sclerosis: The Profile Project.
Internet-based social networking and its role in the evolution of chronic cerebrospinal venous insufficiency.
[The role of chronic venous insufficiency in the pathogenesis of brain diseases].
Minocin
Age-Dependent Seroprevalence of JCV Antibody in Children.
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Fat-soluble vitamins as disease modulators in multiple sclerosis.
Managing MS: Trends, Issues, and Perspectives.
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.
Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.
Spinal cord injury is related to an increased risk of multiple sclerosis: a population-based, propensity score-matched, longitudinal follow-up study.
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)
Clinical Proton MR Spectroscopy in Central Nervous System Disorders.
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Mycovirus-like DNA virus sequences from cattle serum and human brain and serum samples from multiple sclerosis patients.
3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis.
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.
Multiple sclerosis and the spinal cord.

Pages